These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 476778)

  • 1. Studies on the mechanism of haemopoietic stem cell (CFUs) mobilization. A role of the complement system.
    Wilschut IJ; Erkens-Versluis ME; Ploemacher RE; Benner R; Vos O
    Cell Tissue Kinet; 1979 May; 12(3):299-311. PubMed ID: 476778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further studies on mobilization of CFUs.
    Vos O; Wilschut IJ
    Cell Tissue Kinet; 1979 May; 12(3):257-67. PubMed ID: 476774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of serum complement levels on the mobilization of mature white blood cells in relation to mobilization of CFUS.
    Ploemacher RE; Erkens-Versluis ME; Paques M; Wilschut IJ; Vos O
    Exp Hematol; 1980 May; 8(5):626-34. PubMed ID: 6161835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement split product C5a mediates the lipopolysaccharide-induced mobilization of CFU-s and haemopoietic progenitor cells, but not the mobilization induced by proteolytic enzymes.
    Molendijk WJ; van Oudenaren A; van Dijk H; Daha MR; Benner R
    Cell Tissue Kinet; 1986 Jul; 19(4):407-17. PubMed ID: 3533267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of lipopolysaccharide-induced mobilization of CFUs. Dissociation between early and delayed mobilization of CFUs in complement C5-deficient mice and LPS non-responder mice.
    Benner R; Rijnbeek AM; Molendijk W; Vos O
    Cell Tissue Kinet; 1981 Mar; 14(2):143-51. PubMed ID: 7471163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilization of haemopoietic stem cells (CFU) into the peripheral blood of the mouse; effects of endotoxin and other compounds.
    Vos O; Buurman WA; Ploemacher RE
    Cell Tissue Kinet; 1972 Nov; 5(6):467-79. PubMed ID: 4569900
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of the alternate pathway in chelated serum.
    Forsgren A; Mclean RH; Michael AF; Quie PG
    J Lab Clin Med; 1975 Jun; 85(6):904-12. PubMed ID: 805816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substances that can trigger activation of the alternative pathway of complement have anti-melanoma activity in mice.
    Cooper PD; Sim RB
    Int J Cancer; 1984 May; 33(5):683-7. PubMed ID: 6724743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH; Townsend K; Michael AF
    Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum.
    Edens RE; Linhardt RJ; Bell CS; Weiler JM
    Immunopharmacology; 1994; 27(2):145-53. PubMed ID: 8014028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of chemotactic factor generation in C1q-deficient sera.
    Leyva-Cobián F; Clerici N
    Int Arch Allergy Appl Immunol; 1983; 71(2):151-5. PubMed ID: 6601627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of murine complement by cobra venom factor in the presence of EDTA.
    Goldman JN; Bangalore S; Goldman MB
    J Immunol; 1979 Nov; 123(5):2421-7. PubMed ID: 114590
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of C3 depletion on the genesis of thrombocytopenia induced in rats by Erysipelothrix rhusiopathiae.
    Nakato H; Shinomiya K; Mikawa H
    Scand J Haematol; 1986 Jul; 37(1):18-24. PubMed ID: 3764331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced post-irradiation recovery of the haemopoietic system in animals pretreated with a variety of cytotoxic agents.
    Millar JL; Blackett NM; Hudspith BN
    Cell Tissue Kinet; 1978 Sep; 11(5):543-53. PubMed ID: 719696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cobra complement system: I. The alternative pathway of activation.
    Vogel CW; Müller-Eberhard HJ
    Dev Comp Immunol; 1985; 9(2):311-25. PubMed ID: 3894085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death.
    Drake WP; Pokorney DR; Kopyta LP; Mardiney MR
    Biomedicine; 1976 May; 25(3):91-4. PubMed ID: 949521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the possible involvement of complement component C3 in the initiation of acid hydrolase secretion by macrophages. I. Correlation between enzyme-releasing and complement-activating capacities of several secretagogues.
    Riches DW; Stanworth DR
    Immunology; 1981 Sep; 44(1):29-39. PubMed ID: 7275186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-independence of the acute-phase production of serum amyloijd P-component (SAP) in mice.
    Pepys MB; Rogers SL
    Br J Exp Pathol; 1980 Apr; 61(2):156-9. PubMed ID: 7000131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement in the serum and venom of Brazilian snakes (Crotalidae).
    Dias da Silva W; Calich VL; Kipnis TL; Rosen FS; Alper CA
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():97-103. PubMed ID: 6587747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decomplementation with cobra venom factor prolongs survival of xenografted islets in a rat to mouse model.
    Oberholzer J; Yu D; Triponez F; Cretin N; Andereggen E; Mentha G; White D; Buehler L; Morel P; Lou J
    Immunology; 1999 May; 97(1):173-80. PubMed ID: 10447729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.